Equity Brief · Basic Materials2026-09-01
NRF.RO·Basic Materials

Norofert SA Bucuresti

I · AI Analysis

The brief

Norofert manufactures organic and biological agricultural inputs including fertilizers, seed treatments, fungicides, insecticides, and biostimulators for commercial farmers and hobby gardeners, primarily in Romania and increasingly in Brazil.

Norofert is a Romanian agricultural inputs company that produces organic fertilizers, seed treatments, and soil products for farmers across Europe and South America. The company is currently building a second manufacturing plant in Brazil with a €2 million investment, targeting the country's 96 million hectares of farmland [Revista Ferma]. However, trailing-twelve-month revenue through 31 March 2026 fell 43% year-over-year to RON 34.9M, and the company carries net debt at 5.1x EBITDA despite posting a negative net margin [Yahoo Finance].

The company faces significant financial stress with sharply declining revenue, negative profitability, and elevated debt.

The brief AI analysisConfidence 4/10

Sentinellis health

Significant risks

3.6/10

7.5+ strong · 4.5–7.5 moderate · under 4.5 weak

Profitability

27% of score3.3/10
Net margin-3.2%· need > 5%Gross margin+45.6%

Returns on capital

9% of score0.0/10
ROIC—· no dataReturn on equity-3.3%· need > 12%

Growth & momentum

18% of score0.0/10
Revenue growth-43.2%· need > +5% YoYOperating margin trend—· no data

Balance sheet

45% of score6.0/10
Current ratio1.7xNet debt / EBITDA5.1x· need < 2.5xInterest coverage—· no dataDebt / equity0.94

Cash generation

no data
Free cash flow—· no dataCash vs reported profit—· no data

Value creation

no data
ROIC vs cost of capital—· no data

Sentinellis calculation from the published statements — not a score reported by any data source. Each category is scored on the checks that had data; missing inputs are excluded rather than counted as failures.

Market capitalisation

RON 102.3M

Revenue (TTM)

RON 34.9M

Explainers

How we read these numbers

Plain-English guides · no account needed

II · Recent news

What moved

4 stories · ranked by relevance

  • Company2026-08-12

    Norofert construiește o nouă fabrică de inputuri pentru agricultura bio și un laborator de cercetare în Brazilia - Revista Ferma

    Revista Ferma

  • Company2026-08-10

    Romanian agricultural inputs producer Norofert to build second plant in Brazil - Romania Insider

    Romania Insider

  • Company2026-08-10

    Norofert se extinde cu o nouă fabrică în Brazilia. Investiția, estimată la 2 milioane de euro - Economedia

    Economedia

  • Company2026-08-10

    Norofert investeşte 2 milioane de euro în construcţia unei noi fabrici de inputuri în Brazilia, o piaţă de aproximativ 96 de milioane de hectare de teren agricol - News.ro

    news.ro

Premium · Free with any account

Revenue collapsed 43% year-over-year through March 2026, the steepest decline in the company's recent history, with no explanation provided in available data [Yahoo Finance]

1 of 5 risks in this report

Risks

5

Opportunities

4

Red flags

4

Leadership

3

12 more findings in the full report — free with any account.

Unlock the full Norofert SA Bucuresti analysis

Create a free account to access the complete AI-generated report with inline citations.

  • 5 risks, 4 opportunities and 4 red flags — each with its source
  • 100+ financial metrics with charts and benchmarks
  • Full news summaries with source links
  • Executive team and compensation details
Unlock all 13 findings3 free reports · No credit card

III · Related

You might also read

Same sector · Basic Materials — or comparable health

Want this for your watchlist?

Read three companies free. No card.

Get 3 free reports

Produced 01 Sept 2026, 08:55 UTC

Figures come from company filings and market data. The Sentinellis health score and the wording attached to it are our interpretation of those figures, not numbers the company reported.

Not investment advice and not a recommendation to buy or sell. Sentinellis holds no positions in the companies it covers, takes no payment from issuers, and has no broker referral arrangements.

How every figure and score is calculated